Disease: Hyperphosphatemia
- A 47-Year-Old Man with Hyperphosphatemia Due to Chronic Renal Failure Treated with Lanthanum Carbonate Tablets Presenting Acutely with Partial Large Bowel Obstruction
- A Case of Pseudohypoparathyroidism Misdiagnosed as Idiopathic Epilepsy for 5 Years: Clinical Analysis and Follow-up Outcomes
- A Case of Transient Hypercalcemia Following Fistulization of a Calcified Mitral Annulus
- A Phase 1 Study of KIN-3248, an irreversible small molecule pan-FGFR inhibitor, in Patients with Advanced FGFR 2/3 Driven Solid Tumors
- A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
- A Rare Reason for Severe Hypocalcemia Following Kidney Transplant: Denosumab Treatment
- A systematic review of online resources for the dietary management of hyperphosphatemia in people with chronic kidney disease
- A Therapeutic Approach in the Management of Chronic Kidney Disease: Plant-Based Dietary Models and Associated Parameters
- Academy of Nutrition and Dietetics Commentary on the Phosphorus Recommendation in the KDOQI Clinical Practice Guidelines for Nutrition in CKD: 2020 Update
- An Open-Label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism
- Association of Circulating Endothelial Nitric Oxide Synthase Levels with Phosphataemia in Patients on Haemodialysis
- Beyond the Norm: Unusual Coexistence of Wilson's Disease and Hypoparathyroidism
- Brazilian Dialysis Survey 2022
- Characteristics, Risk Factors, and Outcomes in Acute Kidney Injury Patients: A Retrospective Cross-Sectional Study, Palestine
- Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience
- Comparative Analysis of Vascular Calcification Risk Factors in Pre-Hemodialysis and Prevalent Hemodialysis Adult Patients: Insights into Calcification Biomarker Associations and Implications for Intervention Strategies in Chronic Kidney Disease
- Corneal and Coronary Calcification in Maintenance Hemodialysis: The Face Is No Index to the Heart
- Cost-Effectiveness and Clinical Outcomes of Secondary Hyperparathyroidism Treatments in Patients with Chronic Kidney Disease
- Dietary phosphate disturbs of gut microbiome in mice
- Dietary Phosphate Educational Materials for Pediatric Chronic Kidney Disease: Are Confused Messages Reducing Their Impact?
- Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2
- Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent models
- Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial
- Effect of the Phosphate Binder Sevelamer Carbonate on the Bioavailability of Enarodustat, an Oral Erythropoiesis Stimulating Agent
- Effects of a single phosphate-enriched test meal on inflammasome activity and postprandial inflammatory markers in healthy subjects
- Effects of the novel sodium-dependent phosphate cotransporter 2b inhibitor DZ1462 on hyperphosphatemia in chronic kidney disease
- Efficacy, tolerability, and safety of the oral phosphate binder VS-505 (AP301)
- Elevated luminal inorganic phosphate suppresses intestinal Zn absorption in 5/6 nephrectomized rats
- Evaluation of a phosphate kinetics model in hemodialysis therapy-Assessment of the temporal robustness of model predictions
- Excess phosphate promotes SARS‑CoV‑2 N protein‑induced NLRP3 inflammasome activation via the SCAP‑SREBP2 signaling pathway
- Expansion of Phenotypic Spectrum in Hyperphosphatemic Familial Tumoral Calcinosis
- Exploring the association between serum phosphate levels and mortality in patients hospitalized with infectious diseases: a nationwide study
- Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis
- FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
- From ultra-processed foods towards healthy eating for CKD patients: a proposal of educational infographics
- Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations
- Health Economic Benefits of Introducing Sucroferric Oxyhydroxide in the Treatment of Patients with Chronic Kidney Disease under Dialysis in the Kingdom of Saudi Arabia
- Hexametaphosphate, a Common Food Additive, Aggregated the Hen Egg White Lysozyme
- High Phosphate-Induced JAK-STAT Signalling Sustains Vascular Smooth Muscle Cell Inflammation and Limits Calcification
- Human milk derived fortifiers are associated with glucose, phosphorus, and calcium derangements
- Hyperphosphatemia and Zinc Deficiency in Chronic Kidney Disease: Unpacking Their Interconnected Roles and Nutritional Implications
- Hyperphosphatemia With Normal Kidney Function Associated With Genetic Variants of <em>GALNT3</em>
- Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling
- Impaired growth plate maturation in XLH is due to both excess FGF23 and decreased 1,25Dihydroxyvitamin D signaling
- Incidence of Post-Thyroidectomy Hypoparathyroidism and Associated Preoperative and Intraoperative Risk Factors
- Inferring personal intake recommendations of phosphorous and potassium for end-stage renal failure patients by simulating with Bayesian hierarchical multivariate model
- Inorganic Phosphate-Induced Extracellular Vesicles from Vascular Smooth Muscle Cells Contain Elevated Levels of Hyaluronic Acid, Which Enhance Their Interaction with Very Small Superparamagnetic Iron Oxide Particles
- Interpreting epigenetic causes of recurrent hypokalemia and seizures: Gitelman syndrome co-exist with pseudohypoparathyroidism type 1B
- Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease
- Larotrectinib versus infigratinib for adult patients with both glioma and tyrosine kinase alterations after failure of initial therapies: Efficacy and safety analysis
- Left ventricular strain and myocardial work in short-term peritoneal dialysis patients
- lncRNA FAS-AS1 served as a diagnostic biomarker of end-stage renal disease and mediated vascular calcification via regulating oxidative stress and inflammation
- Longitudinal Assessment of Health-Related Quality of Life in Three Different Hyperphosphatemia Management Groups of Stage III and IV Chronic Kidney Disease Patients
- Machine learning based biomarker discovery for chronic kidney disease-mineral and bone disorder (CKD-MBD)
- Mediterranean Diet for Cardiovascular Risk Reduction in Chronic Kidney Disease
- Nephrology: What You May Have Missed in 2023
- Neurological manifestations of hypoparathyroidism: diagnostic difficulties. Case report
- Parathyroid Allotransplantation: Report of Outcomes in 3 Patients
- Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies
- Pemigatinib: A Review in Advanced Cholangiocarcinoma
- Peritoneal Phosphate Clearance: Determinants and Association With Mortality
- Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications
- Phosphate-sensing mechanisms and functions of phosphate as a first messenger
- Phosphonoformic acid reduces hyperphosphatemia-induced vascular calcification via Pit-1
- Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients
- Plant-based diets in patients with chronic kidney disease
- Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients
- Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B<sub>6</sub> metabolism
- Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia
- Reducing the risk of denosumab-induced hypocalcemia in patients with advanced chronic kidney disease: a quality improvement initiative
- Regulatory effects of nutritional and metabolic disorders on vascular calcification in chronic kidney disease: a narrative review
- Relationship between serum phosphorus and mortality in non-dialysis chronic kidney disease patients: evidence from NHANES 2001-2018
- Retrospective analysis of predictive factors for AVF dysfunction in patients undergoing MHD
- Runx2 Regulates <em>Galnt3</em> and <em>Fgf23</em> Expressions and Galnt3 Decelerates Osteoid Mineralization by Stabilizing Fgf23
- Safety Profile and Adverse Event Management for Futibatinib, an Irreversible FGFR1-4 Inhibitor: Pooled Safety analysis of 469 patients
- Seeing the Whole Picture: Evaluating the Contribution of Whole Grains to Phosphorus Exposure in People With Kidney Failure Undergoing Dialysis Treatment
- Serum electrolyte concentrations and risk of atrial fibrillation: an observational and mendelian randomization study
- Serum phosphate levels and the development of sepsis associated acute kidney injury: evidence from two independent databases
- Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells
- Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis
- Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate
- SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease
- Spontaneous tumour lysis secondary to gastric adenocarcinoma
- Spurious Hyperphosphatemia in a Patient with Chronic Kidney Disease - a Rare Case of Alteplase Contamination
- Spurious Hyperphosphatemia in Two Children With End-Stage Renal Disease: A Case Report
- Stability of potassium, calcium and phosphorus electrolytes in three different tubes in patients with essential thrombocytosis
- Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis
- Tenapanor (Xphozah) for hyperphosphatemia in chronic kidney disease
- Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?
- Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study
- Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trial
- The Diagnosis of Albright's Osteodystrophy in a Case With Respiratory Failure
- The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: a randomised, crossover trial
- The Efficacy and Safety of High-Dose Cholecalciferol Therapy in Hemodialysis Patients
- The Magnitude of Change in Serum Phosphate Concentration Is Associated with Mortality in Patients with Severe Trauma
- Therapeutic management of osteodystrophia fibrosa in early weaned Malabari male goat kids
- Three Siblings With a Rare Familial Hyperphosphatemia Syndrome: A Case Series
- Ultrastructural changes of vascular smooth muscle cells and resistance to vasospasm treatment in femoral arteries of an arteriosclerotic rat model
- Vara Deformity and Subluxed Humeral Heads: An Unusual Sign in Pseudohypoparathyroidism
- Vascular Calcification: A Passive Process That Requires Active Inhibition